GALT - Galectin Therapeutics Inc
1.57
0.210 13.376%
Share volume: 239,098
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.36
0.21
0.15%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-15-2024 | 08-13-2024 | 11-14-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 9.648 M | 11.291 M | 9.066 M | |
| Selling general and admin | 1.594 M | 1.478 M | 1.471 M | |
| Research and development | 8.054 M | 9.813 M | 7.595 M | |
| Total expenses | 9.648 M | 11.291 M | 9.066 M | |
| 17.03% | -19.71% | |||
| Operating income | -9.648 M | -11.291 M | -9.066 M | |
| Ebit | -10.517 M | -11.182 M | -9.819 M | |
| Pretax income | -11.489 M | -12.371 M | -11.220 M | |
| 7.68% | -9.30% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -11.489 M | -12.371 M | -11.220 M | |
| -7.68% | 9.30% |
